| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |